Market Tracker

04/26 5:16pm ET

Omeros Corp (NASDAQ:OMER)

16.29
Delayed Data
As of 3:59pm ET
 +0.36 / +2.26%
Today’s Change
7.20
Today|||52-Week Range
17.19
+64.21%
Year-to-Date
Biotech Movers: Organovo, Endo, Omeros
Apr 20 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close15.93
Today’s open15.87
Day’s range15.87 - 16.69
Volume465,782
Average volume (3 months)519,230
Market cap$698.1M
Dividend yield--
Data as of 3:59pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+17.50%
Earnings growth (this year)+25.15%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+208.07%
P/E ratioNM
Price/Sales9.64
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc-0.10-0.50%
CYTKCytokinetics Inc+0.95+5.96%
AMPHAmphastar Pharmaceut...+0.32+2.13%
TGTXTG Therapeutics Inc+0.15+1.25%
Data as of 3:59pm ET, 04/26/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$41.6M
Annual profit (last year)-$66.7M
Net profit margin-160.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts